众生药业：目前已与科兴制药达成昂拉地韦片在中国澳门地区的商业化合作

Core Viewpoint - The company is focusing on international market opportunities for its pharmaceuticals, particularly through a collaboration with Sinovac Biotech for the commercialization of Anglatavir tablets in Macau [1] Group 1: International Expansion - The company has established a commercial partnership with Sinovac Biotech for Anglatavir tablets in Macau, aiming to leverage regional presence for brand expansion [1] - The company plans to explore further international market opportunities and accelerate its globalization efforts [1] Group 2: Market Monitoring and Production - The company is closely monitoring disease dynamics to ensure effective production and sales of its pharmaceuticals [1]